Globus Medical share price logo

Globus Medical

NYSE: GMED

Mid Cap

$75.39

+0.16

(+0.21%)

as on

Globus Medical Stock Performance

as on November 12, 2026 at 7:59 am IST

  • Day's Low

    Day's High

    $74.00
    $75.87
    downward going graph

    1.84%

    Downside

    0.64%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $70.40
    $101.40
    downward going graph

    6.63%

    Downside

    34.50%

    Upside

    downward going graph

Globus Medical share price movements today

Previous Close
$75.23
Open
$74.88
Volume
1.3M
Market Cap
$9.4B
Day's Low - High
$74.00 - $75.87
52 Week Low - High
$70.40 - $101.40

Globus Medical Historical Returns

1 Month Return
+ 0.78 %
3 Month Return
-11.65 %
1 Year Return
-11.43 %
3 Year Return
+ 70.36 %
5 Year Return
+ 2.19 %

Globus Medical Stock Fundamentals & Key Indicators

Check Globus Medical market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$9.4B

EPS (TTM)

4.14

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

18.17

Industry PE ratio

36.04

PEG Ratio

0.56

EBITDA

984.3M

Revenue (TTM)

3.1B

Profit Margin

70.07%

Return On Equity TTM

11.82%

Globus Medical vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Globus Medical with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$9.4B2.19%18.1770.07%0.00%
StrongBuy$58.7B-9.01%58.7678.13%0.00%
Buy$130.2B-15.04%24.8466.69%2.81%
StrongBuy$124.1B23.11%34.3265.52%1.08%
StrongBuy$190.4B-13.19%40.9157.12%2.29%

Stock Returns calculator for Globus Medical Stock including INR - Dollar returns

The Globus Medical stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Globus Medical investment value today

Current value as on today

₹93,987

Returns

-₹6,013

(-6.01%)

Returns from Globus Medical Stock

-₹11,243 (-11.24%)

Dollar Impact

₹5,231 (+5.23%)

Analyst Recommendation on Globus Medical Stock

Based on 6 analysts

BUY

66.67%

Buy

33.33%

Hold

0.00%

Sell

Based on 6 analysts, 66.66666666666666% of analysts recommend a 'BUY' rating for Globus Medical. Average target price of $96.54

Globus Medical Share Price Target

Get share price movements and forecasts by analysts on Globus Medical.

What analysts predicted

21.91%UPSIDE

Target Price

$96.54

Current Price

$75.39

Analyzed by

6 Analysts

High

$105

Target

$96.54

Low

$85

Globus Medical target price $96.54, a slight upside of 21.91% compared to current price of $75.39. According to 6 analysts rating.

Indian Investors' Interest in Globus Medical Stock

Search interest for Globus Medical Stock has decreased by -2% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-2% versus previous 30 day period

Globus Medical Quarterly Profit & Loss

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Total Revenue
629
625
657
598
745
769
826
759
789
763
Gross Profit
369
355
393
402
496
486
595
525
548
530
Operating Income
49
48
60
97
76
135
171
163
182
177
EBITDA
126
115
145
164
193
215
244
226
259
253
Interest Expense
2
0
0
-
-
-
-
-
-
-
Depreciation
63
66
68
66
70
71
70
69
69
70
Income Before Tax
47
57
24
103
188
143
174
157
189
183
Income Tax Expense
15
5
-1
28
-14
25
33
32
38
42
Net Income
31
51
26
75
202
118
140
124
151
141
Net Profit Margin
58.70%
56.77%
59.92%
67.33%
66.62%
63.28%
72.02%
69.20%
69.42%
69.50%

Globus Medical Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
635
712
785
789
958
1,022
1,568
2,519
2,938
Gross Profit
485
553
605
571
718
759
1,020
1,483
1,981
Operating Income
161
169
171
111
171
227
133
165
479
EBITDA
205
218
229
178
264
304
346
473
886
Interest Expense
-
-
-
-
-
-
-
4
-
Depreciation
42
41
52
62
69
68
144
254
276
Income Before Tax
169
188
189
125
180
243
165
120
609
Income Tax Expense
62
32
34
23
31
52
42
17
72
Net Income
107
156
155
102
149
190
122
102
537
Net Profit Margin
76.34%
77.64%
77.08%
72.44%
75.03%
74.22%
65.05%
58.90%
67.41%

Globus Medical Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Net Income
31
51
26
75
202
118
140
124
151
141
Operating Cash Flow
54
203
210
177
77
249
248
202
209
265
Investing Cash Flow
-10
-14
-104
131
-299
-75
-111
-182
-129
-155
Financing Cash Flow
8
19
59
-635
-24
-32
13
18
-134
-130
Change in Cash
56
212
161
-323
-231
142
154
34
-53
-20

Globus Medical Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
107
156
155
102
149
190
122
102
537
Operating Cash Flow
159
181
171
198
276
178
243
520
753
Investing Cash Flow
-111
-193
-140
-117
-375
-110
302
-176
-355
Financing Cash Flow
1
32
24
-38
54
-109
-231
-27
-679
Change in Cash
51
20
55
43
-46
-42
316
317
-258

Global Institutional Holdings in Globus Medical

Check out the Institutions with significant holdings in Globus Medical.

Funds
Holdings
BlackRock, Inc.
9.66%
Vanguard
8.67%
iShares
8.40%
VANGUARD INDEX FUNDS
8.04%
Janus Investment Fund
4.77%

Globus Medical News & Key Events

  • img

    Today's Timeline - 06 November

    Fri, 04:20 PM

    -

    BMO Capital downgrades Globus Medical to Market Perform, lowers price target to $78 after Q3 revenue miss.

    Fri, 06:14 PM

    -

    Canaccord lowers price target on Globus Medical to $105, maintains Buy rating after mixed Q3 results.

    Fri, 07:44 PM

    -

    Wells Fargo raises price target on Globus Medical to $100, keeps Overweight rating despite Q3 sales miss.

  • img

    Today's Timeline - 06 November

    Fri, 11:15 PM

    -

    Truist lowers price target on Globus Medical to $90, maintains Buy rating despite Q3 revenue miss.

    Sat, 00:50 AM

    -

    Globus Medical shares plunge 11.6% after Q3 revenue misses estimates and full-year guidance is lowered.

Insights on Globus Medical

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, GMED has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Edwards Lifesciences Corp has given 22.1% return, outperforming this stock by 33.5%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 789.61M → 763.71M (in $), with an average decrease of 3.3% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, GMED stock has moved down by -13.6%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 151.56M → 141.17M (in $), with an average decrease of 6.9% per quarter

About Globus Medical

Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.
OrganisationGlobus Medical
Headquarters2560 General Armistead Avenue, Audubon, PA, 19403-5214, US
IndustryMedical - Devices
CEOKeith W. Pfeil

Key Management of Globus Medical

Name

Title

Mr. David C. Paul

Co-Founder & Executive Chairman

Mr. Keith W. Pfeil

CEO, President & Director

Mr. Kyle R. Klin

Senior VP & CFO

Ms. Kelly G. Huller Esq.

Executive VP, General Counsel & Corporate Secretary

Mr. Brian J. Kearns

Senior Vice President of Business Development & Investor Relations

FAQs

What is Globus Medical share price today?

Globus Medical share price today is $75.39 as on at the close of the market. Globus Medical share today touched a day high of $75.87 and a low of $74.00.

What is the 52 week high and 52 week low for Globus Medical share?

Globus Medical share touched a 52 week high of $101.40 on and a 52 week low of $70.40 on . Globus Medical stock price today i.e. is closed at $75.39,which is 25.65% down from its 52 week high and 7.10% up from its 52 week low.

What is Globus Medical's market capitalisation today?

Globus Medical market capitalisation is $0.01T as on .

How to invest in Globus Medical Stock (GMED) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Globus Medical on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Globus Medical Stock (GMED) from India?

Indian investors can start investing in Globus Medical (GMED) shares with as little as ₹93.68000030517578 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹936.80 in Globus Medical stock (as per the Rupee-Dollar exchange rate as on ). Based on Globus Medical share’s latest price of $75.39 as on November 12, 2026 at 2:29 am IST, you will get 0.1326 shares of Globus Medical. Learn more about fractional shares .

What are the returns that Globus Medical has given to Indian investors in the last 5 years?

Globus Medical stock has given 2.19% share price returns and 26.4% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?